Check nearby libraries
Buy this book
![Loading indicator](/images/ajax-loader-bar.gif)
Metabolic syndrome is a modern era disease which has engulfed wide regions of the world and the problem is increasing at a rapid pace. The atherogenic dyslipidemia associated with the metabolic syndrome predispose to cardiovascular events. The Statins are considered first-line therapy for treating Dyslipidemia. Clinical response to statins is highly variable and genetic factors play an important role. Sterol regulatory element binding factors (SREBF) – SREBF Cleavage Activating Protein (SCAP) pathway play important roles in lipid metabolism and homeostasis. Identification of genes & genetic variants that influence statin responsiveness holds promise for a safe and effective treatment of Dyslipidemia in Metabolic syndrome.
Check nearby libraries
Buy this book
![Loading indicator](/images/ajax-loader-bar.gif)
Edition | Availability |
---|---|
1
Statin Pharmacogenetics in Metabolic Syndrome- The SREBP-SCAP Pathway
2012, LAP LAMBERT Academic Publishing, LAP Lambert Academic Publishing
Hardcover
in English
3838391977 9783838391977
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Edition Notes
Contributors
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?History
- Created June 1, 2013
- 5 revisions
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
April 14, 2023 | Edited by ImportBot | import existing book |
July 27, 2021 | Edited by ISBNbot2 | normalize ISBN |
June 1, 2013 | Edited by Zahra Hashemi | Add description of the book |
June 1, 2013 | Edited by Zahra Hashemi | Added new cover |
June 1, 2013 | Created by Zahra Hashemi | Added new book. |